Inceptive
inceptive.tech
Artificial Intelligence
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$100M
1 round on record
Latest round
$100M
Venture round · Sep 2023 · 3 yr ago
The money's age
Long since its last round
37 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Web presence
top 10%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2023 | $100M | — | nasdaq.com |
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
On développe des logiciels sur mesure, à des prix de dingue, grâce à l'IA. Testez sur un cas réel.
L’intelligence artificielle au service du diagnostic radiologique du cancer du sein. Hera-MI oriente ses recherches vers l’intelligence…
Excellence : la plateforme IA conçue avec des enseignants. Devoirs sur-mesure, examens, tuteur IA : reprenez la main sur l.
Post Scriptum est une agence web créative et à taille humaine, qui conçoit des sites sur-mesure alliant design et expérience utilisateur…
Hocoia déploie des bus médicaux connectés pour rapprocher la prévention et le dépistage de chaque territoire : check-up santé…
Le premier AI Brand Copilot qui redonne le pouvoir des grandes marques aux entreprises sans service marketing. Diagnostic et stratégie en…
News
Alnylam Pharmaceuticals (ALNY), Inceptive Form $2B Partnership to Advance RNAi Drug Discovery
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is one of the most promising long-term stocks to buy according to analysts. On June 3, Alnylam and Inceptive Nucleics, which builds foundation models of life, announced a collaboration valued at up to $2 billion
Read more
Report
Alnylam, Inceptive sign up to $2 billion AI drug discovery deal
June 3 () - Alnylam Pharmaceuticals said on Wednesday it has teamed up with artificial-intelligence biotech Inceptive in a deal worth up to $2 billion to use AI to speed up discovery of RNA-based medicines. Drugmaker Alnylam will pay $30 million upfront,
Read more
Report
Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeutics
Alnylam announced a three-year collaboration with Inceptive, worth up to $2 billion, with $30 million up front in cash and equity in the startup.
Read more
Report
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics
CAMBRIDGE, Mass. & PALO ALTO, Calif., June 03, 2026--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Inceptive Nucleics, Inc., which builds foundation models of life, today announced a strategic collaboration agree
Read more
Report
Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics
Read more
Report
After leaving Google, Jakob Uszkoreit started Inceptive to apply AI to drug development
Inceptive CEO Jakob Uszkoreit helped invent the tech behind generative AI. Now, he says it will change the pharmaceutical industry by altering how drugs work.
Read more
Report
Inceptive CEO Jakob Uszkoreit on transformers and using AI to make new drugs
Before co-founding AI biotech startup Inceptive, Jakob Uszkoreit helped invent the transformer, the neural network architecture that underpins generative AI. As a researcher at Google in 2017, Uszkoreit was one of the eight authors of the seminal "Attenti
Read more
Report
Financials
Total raised
$100M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2023 | $100M | Details |